Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT

PHASE3CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

December 21, 2020

Study Completion Date

January 29, 2021

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Tegoprazan

Tegoprazan 50 mg or 100 mg/Clarithromycin/Amoxicillin BID peroral

DRUG

RAPAE01

RAPAE01/Clarithromycin/Amoxicillin BID peroral

Trial Locations (1)

Chung-Ang University Hosptial, Seoul